We are developing a bioelectronic solution for migraine
Salvia BioElectronics is pioneering a novel neuromodulation therapy aiming to transform migraine treatment. MySalvia Therapy offers an innovative approach to managing migraine attacks. It features an ultra-thin implant that targets the key nerves involved in migraine and is designed with personalization, ease of use, and comfort in mind.
Salvia is driven by the belief that people with chronic migraine deserve the opportunity to reclaim their lives. Founded in 2017 and headquartered in Eindhoven, The Netherlands, Salvia is led by a team of industry veterans with extensive experience in medical devices and neuromodulation. Active in the United States, Europe and Australia, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its technology for the treatment of cluster headache.
Salvia’s migraine therapy is currently being evaluated in clinical studies. It has not yet been approved for commercial use. No claims are made regarding its safety or effectiveness.
Meet our team
Salvia BioElectronics has experienced remarkable growth over the past seven years. We now have 50+ colleagues from all over the world, representing 15 nationalities. Our home is High Tech Campus Eindhoven, also known as the smartest square kilometer in Europe, where more than 300 high-tech companies are developing the technologies of the future.
Our team
Salvia Selected for MedTech Innovator Accelerator 2024
Salvia BioElectronics is one of the companies selected for the MedTech Innovator Accelerator 2024. "We are absolutely thrilled," says Salvia CEO Hubert Martens. "With over 1300 applicants, only the top 5% made it through the rigorous selection process; this is an amazing group to be a part of. We're looking forward to connecting with like-minded entrepreneurs and are excited to have the opportunity to learn from the best in class and get expert support to further detail and pressure test our commercialization plans."
It is not “just a headache”
Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Cluster headache, which causes excruciating pain behind the eye, is a rare neurological disorder affecting 1 in 1000 people. Read more about both conditions we address with our bioelectronic solution.
Join our team
Our team is growing and we are always looking for passionate and talented individuals who want to be part of our mission to give people with migraine a better life.
We also encourage open applications; please submit yours here!
Acquisition is not appreciated.
.jpg)
Mechanical Engineer
We offer an exciting opportunity for a Mechanical Engineer to join our innovative and collaborative team. In this role, you will work closely with internal development teams and external suppliers, contributing to the design and improvement of active implantable medical devices.
Manufacturing Engineer
You are responsible for the design, procurement, and realization of Salvia’s production and verification equipment. You will execute, supported by process engineering, required validations in line with regulatory requirements, including Equipment, Process & Product validations (IQ/OQ/PQ) and will drive process reliability and yield optimization from initial pilot production towards commercial scaling.
Stay informed
Meet Anja Schaeken, Director Clinical Affairs
“Every day is a challenge. And together, you work toward one goal - a shared mission. With so many different disciplines coming together, that’s what makes working at a startup so exciting,” says Anja Schaeken, Director Clinical Affairs at Salvia BioElectronics.
Meet Zaibunnisa Nasar, Clinical Trial Assistant
Zaibunnisa Malikajan Nasar isn’t into unquestioningly accepting the status quo. “My parents used to say, ‘You are the one who always asks ‘Why?’
Meet Zameed SahebAli, Vice President Product Development
As Employee No. 1 at Salvia Bioelectronics, Zameed SahebAli was asked a simple question: "Would you like to join us on this crazy adventure?"
Meet our investors
Salvia Insights
Starting in 2025, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?
We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.